Skip to main content
Top
Published in:

Open Access 20-05-2024 | Breast Cancer | Research

Intraoperative spectroscopic evaluation of sentinel lymph nodes in breast cancer surgery

Authors: Surekha Barkur, Radu A. Boitor, Raluca Mihai, Navarasi S. Raja Gopal, Samuel Leeney, Alexey A. Koloydenko, Hazem Khout, Emad Rakha, Ioan Notingher

Published in: Breast Cancer Research and Treatment | Issue 1/2024

Login to get access

Abstract

Background and objectives

Sentinel lymph node (SLN) biopsy is a standard procedure for patients with breast cancer and normal axilla on imaging. Positive SLNs on histological examination can lead to a subsequent surgery for axillary lymph node clearance (ALNC). Here we report a non-destructive technique based on autofluorescence (AF) imaging and Raman spectroscopy for intra-operative assessment of SLNs excised in breast cancer surgery.

Methods

A microscope integrating AF imaging and Raman spectroscopy modules was built to allow scanning of lymph node biopsy samples. During AF-Raman measurements, AF imaging determined optimal sampling locations for Raman spectroscopy measurements. After optimisation of the AF image analysis and training of classification models based on data from 85 samples, the AF-Raman technique was tested on an independent set of 81 lymph nodes comprising 58 fixed and 23 fresh specimens. The sensitivity and specificity of AF-Raman were calculated using post-operative histology as a standard of reference.

Results

The independent test set contained 66 negative lymph nodes and 15 positive lymph nodes according to the reference standard, collected from 78 patients. For this set of specimens, the area under the receiver operating characteristic (ROC) curve for the AF-Raman technique was 0.93 [0.83–0.98]. AF-Raman was then operated in a regime that maximised detection specificity, producing a 94% detection accuracy: 80% sensitivity and 97% specificity. The main confounders for SLN metastasis were areas rich in histiocytes clusters, for which only few Raman spectra had been included in the training dataset.

Discussion

This preliminary study indicates that with further development and extension of the training dataset by inclusion of additional Raman spectra of histiocytes clusters and capsule, the AF-Raman may become a promising technique for intra-operative assessment of SLNs. Intra-operative detection of positive biopsies could avoid second surgery for axillary clearance.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hahm GK et al (2001) The value of second opinion in gastrointestinal and liver pathology. Arch Pathol Lab Med 125(6):736–739CrossRefPubMed Hahm GK et al (2001) The value of second opinion in gastrointestinal and liver pathology. Arch Pathol Lab Med 125(6):736–739CrossRefPubMed
3.
go back to reference Caretta-Weyer H et al (2012) Impact of axillary ultrasound and core needle biopsy on the utility of intraoperative frozen section analysis and treatment decision making in women with invasive breast cancer. Am J Surg 204(3):308–314CrossRefPubMed Caretta-Weyer H et al (2012) Impact of axillary ultrasound and core needle biopsy on the utility of intraoperative frozen section analysis and treatment decision making in women with invasive breast cancer. Am J Surg 204(3):308–314CrossRefPubMed
4.
go back to reference Giuliano AE et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569–575CrossRefPubMedPubMedCentral Giuliano AE et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569–575CrossRefPubMedPubMedCentral
5.
go back to reference Veronesi U et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546–553CrossRefPubMed Veronesi U et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546–553CrossRefPubMed
6.
go back to reference Mansel RE et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98(9):599–609CrossRefPubMed Mansel RE et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98(9):599–609CrossRefPubMed
7.
go back to reference Morrow KJ et al (2017) Axillary dissection and nodal irradiation can Be avoided for most node-positive Z0011-eligible breast cancers: a prospective validation study of 793 patients. Ann Surg 266(3):457–462CrossRefPubMed Morrow KJ et al (2017) Axillary dissection and nodal irradiation can Be avoided for most node-positive Z0011-eligible breast cancers: a prospective validation study of 793 patients. Ann Surg 266(3):457–462CrossRefPubMed
8.
go back to reference Straver ME et al (2010) Sentinel node identification rate and nodal involvement in the EORTC 10981–22023 AMAROS trial. Ann Surg Oncol 17(7):1854–1861CrossRefPubMedPubMedCentral Straver ME et al (2010) Sentinel node identification rate and nodal involvement in the EORTC 10981–22023 AMAROS trial. Ann Surg Oncol 17(7):1854–1861CrossRefPubMedPubMedCentral
9.
go back to reference Giuliano AE et al (2017) Effect of axillary dissection vs No axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. J Am Med Assoc 318(10):918–926CrossRef Giuliano AE et al (2017) Effect of axillary dissection vs No axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. J Am Med Assoc 318(10):918–926CrossRef
10.
go back to reference Galimberti V et al (2018) Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23–01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol 19(10):1385–1393CrossRefPubMed Galimberti V et al (2018) Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23–01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol 19(10):1385–1393CrossRefPubMed
12.
go back to reference Jeeravongpanich P et al (2014) Histologic evaluation of sentinel and non-sentinel axillary lymph nodes in breast cancer by multilevel sectioning and predictors of non-sentinel metastasis. Gland Surg 3(1):2–13PubMedPubMedCentral Jeeravongpanich P et al (2014) Histologic evaluation of sentinel and non-sentinel axillary lymph nodes in breast cancer by multilevel sectioning and predictors of non-sentinel metastasis. Gland Surg 3(1):2–13PubMedPubMedCentral
13.
go back to reference Fan Z et al (2013) Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy. Breast 22(6):1161–1165CrossRefPubMed Fan Z et al (2013) Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy. Breast 22(6):1161–1165CrossRefPubMed
14.
go back to reference Barkur S, Notingher I, Rakha E (2022) Intra-operative assessment of sentinel lymph nodes for breast cancer surgery: an update. Surg Oncol 40:101678CrossRefPubMed Barkur S, Notingher I, Rakha E (2022) Intra-operative assessment of sentinel lymph nodes for breast cancer surgery: an update. Surg Oncol 40:101678CrossRefPubMed
15.
go back to reference Shau-Kong L et al (2018) Intraoperative frozen section sentinel lymph node assessment in breast cancer: a tertiary institution experience. Malaysian J Pathol 40(2):121 Shau-Kong L et al (2018) Intraoperative frozen section sentinel lymph node assessment in breast cancer: a tertiary institution experience. Malaysian J Pathol 40(2):121
16.
go back to reference Bell Z, Cameron I, Dace JS (2010) Imprint cytology predicts axillary node status in sentinel lymph node biopsy. Ulst Med J 79(3):119 Bell Z, Cameron I, Dace JS (2010) Imprint cytology predicts axillary node status in sentinel lymph node biopsy. Ulst Med J 79(3):119
17.
go back to reference Tiernan JP et al (2014) Systematic review and meta-analysis of cytokeratin 19-based one-step nucleic acid amplification versus histopathology for sentinel lymph node assessment in breast cancer. Br J Surg 101(4):298–306CrossRefPubMed Tiernan JP et al (2014) Systematic review and meta-analysis of cytokeratin 19-based one-step nucleic acid amplification versus histopathology for sentinel lymph node assessment in breast cancer. Br J Surg 101(4):298–306CrossRefPubMed
18.
go back to reference Shi F et al (2017) One-step nucleic acid amplification assay is an accurate technique for sentinel lymph node biopsy of breast cancer patients: a meta-analysis. Br J Cancer 117(8):1185–1191CrossRefPubMedPubMedCentral Shi F et al (2017) One-step nucleic acid amplification assay is an accurate technique for sentinel lymph node biopsy of breast cancer patients: a meta-analysis. Br J Cancer 117(8):1185–1191CrossRefPubMedPubMedCentral
19.
go back to reference Castellano I et al (2012) Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases. Ann Surg 255(2):334–342CrossRefPubMed Castellano I et al (2012) Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases. Ann Surg 255(2):334–342CrossRefPubMed
20.
go back to reference Vilardell F et al (2012) Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA. Virchows Arch 460(6):569–575CrossRefPubMedPubMedCentral Vilardell F et al (2012) Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA. Virchows Arch 460(6):569–575CrossRefPubMedPubMedCentral
21.
go back to reference Jaafar H (2006) Intra-operative frozen section consultation: concepts, applications and limitations. Malaysian J Med Sci MJMS 13(1):4 Jaafar H (2006) Intra-operative frozen section consultation: concepts, applications and limitations. Malaysian J Med Sci MJMS 13(1):4
22.
23.
go back to reference Lee TK (1982) The value of imprint cytology in tumor diagnosis: a retrospective study of 522 cases in northern China. Acta Cytol 26(2):169–171PubMed Lee TK (1982) The value of imprint cytology in tumor diagnosis: a retrospective study of 522 cases in northern China. Acta Cytol 26(2):169–171PubMed
24.
go back to reference Shipp D et al (2017) Raman spectroscopy: techniques and applications in the life sciences. Adv Optics Photonics 9(2):p315CrossRef Shipp D et al (2017) Raman spectroscopy: techniques and applications in the life sciences. Adv Optics Photonics 9(2):p315CrossRef
25.
go back to reference Ralbovsky NM, Lednev IK (2020) Towards development of a novel universal medical diagnostic method: Raman spectroscopy and machine learning. Chem Soc Rev 49:p7428CrossRef Ralbovsky NM, Lednev IK (2020) Towards development of a novel universal medical diagnostic method: Raman spectroscopy and machine learning. Chem Soc Rev 49:p7428CrossRef
26.
go back to reference Horsnell JD et al (2012) Raman spectroscopy—a potential new method for the intra-operative assessment of axillary lymph nodes. The Surgeon 10(3):123–127CrossRefPubMed Horsnell JD et al (2012) Raman spectroscopy—a potential new method for the intra-operative assessment of axillary lymph nodes. The Surgeon 10(3):123–127CrossRefPubMed
27.
go back to reference Horsnell J et al (2010) Raman spectroscopy—a new method for the intra-operative assessment of axillary lymph nodes. Analyst 135(12):3042–3047CrossRefPubMed Horsnell J et al (2010) Raman spectroscopy—a new method for the intra-operative assessment of axillary lymph nodes. Analyst 135(12):3042–3047CrossRefPubMed
28.
go back to reference Lloyd GR et al (2013) Discrimination between benign, primary and secondary malignancies in lymph nodes from the head and neck utilising Raman spectroscopy and multivariate analysis. Analyst 138(14):3900–3908CrossRefPubMed Lloyd GR et al (2013) Discrimination between benign, primary and secondary malignancies in lymph nodes from the head and neck utilising Raman spectroscopy and multivariate analysis. Analyst 138(14):3900–3908CrossRefPubMed
29.
go back to reference Rowlands CJ et al (2012) Rapid acquisition of Raman spectral maps through minimal sampling: applications in tissue imaging. J Biophotonics 5(3):220–229CrossRefPubMed Rowlands CJ et al (2012) Rapid acquisition of Raman spectral maps through minimal sampling: applications in tissue imaging. J Biophotonics 5(3):220–229CrossRefPubMed
30.
go back to reference Kong K et al (2013) Diagnosis of tumors during tissue-conserving surgery with integrated autofluorescence and Raman scattering microscopy. Proc Natl Acad Sci 110(38):15189–15194CrossRefPubMedPubMedCentral Kong K et al (2013) Diagnosis of tumors during tissue-conserving surgery with integrated autofluorescence and Raman scattering microscopy. Proc Natl Acad Sci 110(38):15189–15194CrossRefPubMedPubMedCentral
31.
33.
go back to reference Boitor R et al (2017) Automated multimodal spectral histopathology for quantitative diagnosis of residual tumour during basal cell carcinoma surgery. Biomed Opt Express 8(12):5749–5766CrossRefPubMedPubMedCentral Boitor R et al (2017) Automated multimodal spectral histopathology for quantitative diagnosis of residual tumour during basal cell carcinoma surgery. Biomed Opt Express 8(12):5749–5766CrossRefPubMedPubMedCentral
34.
go back to reference Takamori S et al (2015) Optimization of multimodal spectral imaging for assessment of resection margins during Mohs micrographic surgery for basal cell carcinoma. Biomed Opt Express 6(1):98–111CrossRefPubMed Takamori S et al (2015) Optimization of multimodal spectral imaging for assessment of resection margins during Mohs micrographic surgery for basal cell carcinoma. Biomed Opt Express 6(1):98–111CrossRefPubMed
35.
go back to reference Liao Z et al (2018) Optical sectioning in multifoci Raman hyperspectral imaging. J Raman Spectrosc 49(10):1660–1667CrossRef Liao Z et al (2018) Optical sectioning in multifoci Raman hyperspectral imaging. J Raman Spectrosc 49(10):1660–1667CrossRef
36.
go back to reference Sinjab F et al (2016) Tissue diagnosis using power-sharing multifocal Raman micro-spectroscopy and auto-fluorescence imaging. Biomed Opt Express 7(8):2993–3006CrossRefPubMedPubMedCentral Sinjab F et al (2016) Tissue diagnosis using power-sharing multifocal Raman micro-spectroscopy and auto-fluorescence imaging. Biomed Opt Express 7(8):2993–3006CrossRefPubMedPubMedCentral
37.
go back to reference Sanne AL et al (2023) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981–22023 AMAROS trial. J Clin Oncol 41(12):2159–2165CrossRef Sanne AL et al (2023) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981–22023 AMAROS trial. J Clin Oncol 41(12):2159–2165CrossRef
Metadata
Title
Intraoperative spectroscopic evaluation of sentinel lymph nodes in breast cancer surgery
Authors
Surekha Barkur
Radu A. Boitor
Raluca Mihai
Navarasi S. Raja Gopal
Samuel Leeney
Alexey A. Koloydenko
Hazem Khout
Emad Rakha
Ioan Notingher
Publication date
20-05-2024
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2024
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-024-07349-z

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Dr. Vivek Subbiah
Dr. Alexander Drilon
Dr. Michelle Williams
Developed by: Springer Healthcare
Watch now
Video

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more